PIK3CA and breast cancer: Somatic mutations in the PIK3CA gene, which encodes the p110α catalytic subunit of the PI3Kα complex, are the most frequent genetic alterations observed in HR+/HER2− BC, occurring in approximately 20% to 40% of patients.